The FUS/EWSR1-DDIT3 fusion characteristic of myxoid liposarcoma can be distinguished from LLT using DDIT3 immunohistochemistry, in which nuclear anti-DDIT3 immunoreactivity is a highly sensitive and specific marker of myxoid/round cell liposarcoma [9]. Here, DDIT3 is linked to round cell liposarcoma.